These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31481723)
1. Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate. Bergin DH; Jing Y; Williams G; Mockett BG; Zhang H; Abraham WC; Liu P Sci Rep; 2019 Sep; 9(1):12669. PubMed ID: 31481723 [TBL] [Abstract][Full Text] [Related]
2. Altered plasma arginine metabolome precedes behavioural and brain arginine metabolomic profile changes in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Bergin DH; Jing Y; Mockett BG; Zhang H; Abraham WC; Liu P Transl Psychiatry; 2018 May; 8(1):108. PubMed ID: 29802260 [TBL] [Abstract][Full Text] [Related]
3. Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain. Zhu MY; Wang WP; Cai ZW; Regunathan S; Ordway G Eur J Neurosci; 2008 Mar; 27(6):1320-32. PubMed ID: 18364017 [TBL] [Abstract][Full Text] [Related]
4. Evidence for oral agmatine sulfate safety--a 95-day high dosage pilot study with rats. Gilad GM; Gilad VH Food Chem Toxicol; 2013 Dec; 62():758-62. PubMed ID: 24140462 [TBL] [Abstract][Full Text] [Related]
5. Involvement of nitric oxide in anticompulsive-like effect of agmatine on marble-burying behaviour in mice. Gawali NB; Chowdhury AA; Kothavade PS; Bulani VD; Nagmoti DM; Juvekar AR Eur J Pharmacol; 2016 Jan; 770():165-71. PubMed ID: 26593708 [TBL] [Abstract][Full Text] [Related]
6. Agmatine crosses the blood-brain barrier. Piletz JE; May PJ; Wang G; Zhu H Ann N Y Acad Sci; 2003 Dec; 1009():64-74. PubMed ID: 15028571 [TBL] [Abstract][Full Text] [Related]
8. Neuropharmacokinetic and dynamic studies of agmatine (decarboxylated arginine). Nguyen HO; Goracke-Postle CJ; Kaminski LL; Overland AC; Morgan AD; Fairbanks CA Ann N Y Acad Sci; 2003 Dec; 1009():82-105. PubMed ID: 15028573 [TBL] [Abstract][Full Text] [Related]
9. The pharmacological importance of agmatine in the brain. Uzbay TI Neurosci Biobehav Rev; 2012 Jan; 36(1):502-19. PubMed ID: 21893093 [TBL] [Abstract][Full Text] [Related]
10. Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling. Kang S; Kim CH; Jung H; Kim E; Song HT; Lee JE Neuropharmacology; 2017 Feb; 113(Pt A):467-479. PubMed ID: 27810390 [TBL] [Abstract][Full Text] [Related]
12. Biodistribution of Agmatine to Brain and Spinal Cord after Systemic Delivery. Clements BM; Peterson CD; Kitto KF; Caye LD; Wilcox GL; Fairbanks CA J Pharmacol Exp Ther; 2023 Dec; 387(3):328-336. PubMed ID: 37770201 [TBL] [Abstract][Full Text] [Related]
13. Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice. Freitas AE; Bettio LE; Neis VB; Moretti M; Ribeiro CM; Lopes MW; Leal RB; Rodrigues AL J Psychiatr Res; 2014 Nov; 58():137-46. PubMed ID: 25161097 [TBL] [Abstract][Full Text] [Related]
14. Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid β (Aβ1-40) administration in mice. Guerra de Souza AC; Gonçalves CL; de Souza V; Hartwig JM; Farina M; Prediger RD Behav Brain Res; 2018 Nov; 353():51-56. PubMed ID: 29964071 [TBL] [Abstract][Full Text] [Related]
15. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554 [TBL] [Abstract][Full Text] [Related]
16. Agmatine inhibits nicotine withdrawal induced cognitive deficits in inhibitory avoidance task in rats: Contribution of α Kotagale NR; Ali MT; Chopde CT; Umekar MJ; Taksande BG Pharmacol Biochem Behav; 2018 Apr; 167():42-49. PubMed ID: 29530492 [TBL] [Abstract][Full Text] [Related]
17. Hypotensive effect of agmatine, arginine metabolite, is affected by NO synthase. Gerová M; Török J Physiol Res; 2004; 53(4):357-63. PubMed ID: 15311993 [TBL] [Abstract][Full Text] [Related]
18. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon. Baño Otalora B; Popovic N; Gambini J; Popovic M; Viña J; Bonet-Costa V; Reiter RJ; Camello PJ; Rol MÁ; Madrid JA Chronobiol Int; 2012 Aug; 29(7):822-34. PubMed ID: 22823866 [TBL] [Abstract][Full Text] [Related]